Nivolumab vs Pantoprazole
Nivolumab vs Pantoprazole: Overview
This comparison examines the pharmacological differences between Nivolumab and Pantoprazole.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pantoprazole: Proton pump inhibitor.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Pantoprazole β 1 hour.
Chemical Properties
Molecular Formula: Pantoprazole β C16H15F2N3O4S.
Molecular Weight: Pantoprazole β 383.3710 g/mol.
Type: Nivolumab β Antibody; Pantoprazole β Small molecule.